Clinical and research tests for C1838547 - Genetic Testing Registry (GTR) - NCBI

Warning: The NCBI web site requires JavaScript to function. more...

<< First < Prev

Page 2 of 4

Results: 21 to 40 of 70

Tests names and labs	Conditions	Genes, analytes, and microbes	Methods
Variant Resolution Test for CancerNext® 37 (+RNAinsight®) Ambry Genetics United States	79	18	D Deletion/duplication analysis R RNA analysis C Sequence analysis of the entire coding region
Variant Resolution Test for Penn Cancer Grant Panel (+RNAinsight®) Ambry Genetics United States	79	18	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Penn Cancer Grant Panel Ambry Genetics United States	79	80	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Pancreatic cancer/melanoma syndrome, 606719, Autosomal dominant (Familial atypical multiple mole melanoma syndrome) (MLPA) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey	1	1	D Deletion/duplication analysis
Pancreatic cancer/melanoma syndrome, 606719, Autosomal dominant (Familial atypical multiple mole melanoma syndrome) (CDKN2A gene) (Sequence Analysis-All Coding Exons) (Postnatal) Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey	1	1	C Sequence analysis of the entire coding region
Invitae Genetic Health Screen Labcorp Genetics (formerly Invitae) LabCorp United States	409	164	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Invitae Cancer Screen Labcorp Genetics (formerly Invitae) LabCorp United States	160	62	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Variant Resolution Test for CustomNext-Cancer® (+RNAinsight®) Ambry Genetics United States	90	90	D Deletion/duplication analysis R RNA analysis C Sequence analysis of the entire coding region
Variant Resolution Test for CancerNext-Expanded® (+RNAinsight®) Ambry Genetics United States	88	90	D Deletion/duplication analysis R RNA analysis C Sequence analysis of the entire coding region
CDKN2A and CDK4 gene sequence and deletion/duplication Ambry Genetics United States	4	2	D Deletion/duplication analysis C Sequence analysis of the entire coding region
CancerNext-Expanded® Ambry Genetics United States	86	89	D Deletion/duplication analysis C Sequence analysis of the entire coding region
Pancreatic Cancer Panel PreventionGenetics, part of Exact Sciences United States	27	18	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Cancer Panel PreventionGenetics, part of Exact Sciences United States	122	117	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
Melanoma Predisposition via the CDKN2A Gene PreventionGenetics, part of Exact Sciences United States	2	1	D Deletion/duplication analysis C Sequence analysis of the entire coding region T Targeted variant analysis
myRisk Single Site Analysis Myriad Genetics, Inc. United States	32	45	T Targeted variant analysis
Inherited Cancer Panel Dhiti Omics Technologies Private Ltd India	135	84	C Sequence analysis of the entire coding region
Bone marrow failure syndrome panel. NGS panel of 122 genes. Genologica Medica Spain	194	122	C Sequence analysis of the entire coding region
Hereditary leukemia panel. NGS panel of 39 genes. Genologica Medica Spain	89	39	C Sequence analysis of the entire coding region
Hereditary lung cancer panel. Panel NGS genes: BRCA2, CDKN2A, EGFR, TP53. Genologica Medica Spain	23	4	C Sequence analysis of the entire coding region
Hereditary pancreatic cancer panel. NGS panel of 22 genes. Genologica Medica Spain	61	22	C Sequence analysis of the entire coding region

<< First < Prev

Page 2 of 4

Results: 21 to 40 of 70

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.